NASALE ABGABEVORRICHTUNGEN

European patent · EP1799290 · Deleted

Register entry

Publication number
EP1799290
Application number
EP05789130
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Sep 15, 2005
Published
Jun 27, 2007
Granted
Aug 12, 2015
Deleted
Apr 24, 2024
Reason
Annual fee unpaid
IPC classes
A61M 15/00 (2006.01)
Priority
GB 0420513 15.09.2004
PCT application
PCT/GB2005/003549 15.09.2005
PCT publication
WO2006/030210 23.03.2006
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Apr 24, 2024

    Deleted, fee unpaid

    Published in Swissreg on 24.04.2024

  2. Oct 18, 2022

    Transferred

    Owner
    Optinose AS, Oslo Innovation Center, Gaustadalléen 21, 0349 Oslo, Norway → OPTINOSE, INC., 1020 Stony Hill Road, Ste 300, Yardley, PA 19067, USA

    Published in Swissreg on 18.10.2022

  3. Oct 1, 2022

    Change

    Published in Swissreg on 01.10.2022

  4. Aug 12, 2015

    Granted

    Published in Swissreg on 12.08.2015

  5. Aug 12, 2015

    Agent entered

    Representative
    Hepp Wenger Ryffel AG, Friedtalweg 5, 9500 Wil / SG

    Published in Swissreg on 12.08.2015

Parties

Holder

OPTINOSE, INC.

1020 Stony Hill Road, Ste 300, Yardley, PA 19067, US

Agent

Hepp Wenger Ryffel AG

Friedtalweg 5, 9500 Wil / SG

Inventor

DJUPESLAND, Per Gisle, Optinose AS

N-0349 Oslo, NO

HAFNER, Roderick Peter, Optinose UK Ltd

South Marston Park, Wiltshire SN3 4TG, GB

SHELDRAKE, Colin David, Optinose UK Ltd

South Marston Park, Wiltshire SN3 4TG, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.